Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)

Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)

US Patent 9744223 · Granted Aug 29, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bacteriophage compositions and methods of selection of components against specif2025
Method for purification of bacteriophage particles2024
Phage dispensing system2024
Bacteriophage-based vaccines and engineered bacteriophage2023
Fibrous nerve conduit for promoting nerve regeneration2022
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxy2020
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxy2020
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxy2020
Treatment for chemotherapy-induced cognitive impairment2020
Treatment for chemotherapy-induced peripheral neuropathy2020
Bacteriophage compositions and methods of selection of components against specif2019
System and method for enhanced emulation of connected vehicle applications2019